Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Notice of AGM

22 March 2023 11:00 GMT Notice of Annual General Meeting and Board Committee change AstraZeneca PLC (the Company) announced today the publication of its Notice of Annual General Meeting 2023 and Shareholders’ Circular (the Notice). The Company also announced that, in line with the UK Corporate Governance Code, Michel Demaré will step down as a member of the Audit Committee at the conclusion of this year’s Annual General Meeting (AGM) following his appointment as Chair of the Board. The Notice and the proxy form for the AGM have been submitted to the National Storage Mechanism

Energy-efficient tires make a difference – How can drivers affect the carbon footprint of their tires?

Fuel consumption during driving accounts for the biggest environmental impact over a tire’s lifecycle. By choosing tires with low rolling resistance and checking tire pressures regularly, the driver can both improve the energy efficiency and contribute to the eco-friendliness of driving. Also other factors, such as raw materials and the emissions from manufacturing, affect the carbon footprint of tires.  “There are many concrete ways for drivers to make a positive impact on eco-friendliness in traffic. Over 80% of a tire’s carbon footprint is created during its use. A wise choice of

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release March 22, 2023 at 12:45 p.m. Nokian Tyres has received an announcement from The Goldman Sachs Group, Inc. on March 21, 2023, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement, the total holding in Nokian Tyres shares and voting rights owned by The Goldman Sachs Group, Inc. indirect and through financial instruments fell below the level of 5% as a result of share transactions concluded on March 20, 2023. The total shareholding of The Goldman Sachs Group, Inc. and its controlled undertakings

Orkla ASA – Issuance of Commercial Paper

Orkla ASA has issued a new commercial paper of NOK 600,000,000.Start date:                   24 March 2023 Maturity:                     21 April 2023 Coupon:                      3.475 % Organised by:             Handelsbanken Capital Markets     Orkla ASA Oslo, 22 March 2023     Ref.: Senior Vice President Group Treasury Geir Solli Tel.: +47 995 42 789

BioStock: Chordate’s CEO on entering new markets

How does Chordate Medical’s treatment for rhinitis and chronic migraine work? What market interest has the company seen and what strategy is it working with to gain market share? In connection with the BioStock Investor Meeting, the company’s CEO Anders Weilandt talked about this, among other things.Watch the interview with Anders Weilandt at biostock.se:https://www.biostock.se/en/2023/03/chordates-ceo-on-entering-new-markets/This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

“Now, more than ever, is the time for truly effective sustainability actions” – Tokmanni presents its sustainability work in its Sustainability Report 2022

Tokmanni     Press release     22 March 2023 at 12:30 p.m. Tokmanni has published its Sustainability Report 2022  today, Wednesday 22 March 2023. In its sustainability report, Sustainability available for all, Tokmanni demonstrates how it combines low prices with sustainability. In addition to highlighting its successful actions, Tokmanni describes challenges in sustainability work. In addition to its English-language sustainability report, which is prepared in accordance with the GRI standards*, Tokmanni has published

Nightingale Health Plc: Unaudited financial information in accordance with IFRS for the comparative half-year periods

Company release, 22 March 2023 at 12 p.m. (EET) Nightingale Health Plc ("Nightingale Health" or the "Company") published on 27 October 2022 its first consolidated financial statements prepared in accordance with IFRS for the financial year ended 30 June 2022. Before publishing the consolidated financial statements Nightingale Health provided comparative information on its consolidated statement of income, statement of financial position and key financials for the financial year ended 30 June 2021 and for the opening IFRS statement of financial position as at the transition date, 1 July

Deputy Governor Henry Ohlsson will leave the Riksbank at the end of June

Deputy Governor Henry Ohlsson has informed the Chair of the General Council Bo Broman that he will resign as Deputy Governor on 30 June 2023."I have been Deputy Governor of the Riksbank for more than eight years and they have in many ways been the best years in my professional life. I have been given the opportunity to apply the knowledge and experience I have with me from my time in the academic world to do what is best for Sweden. It has been a pleasure to make this journey together with all the knowledgeable employees at the Riksbank and my colleagues on the Executive Board. Nevertheless,

Breakthrough in plant-based production of Cyxone’s T20K

Cyxone (publ), a biotech company in autoimmune diseases, is developing T20K which acts to stop or slow down the progression of Multiple Sclerosis (MS). Researchers at the well renowned Center of Excellence for Innovations in Peptide and Protein Science, Australia have demonstrated a breakthrough in plant-based production of Cyxone’s T20K.The research findings means that sustainable, large scale and cost-effective production of cyclotide-based pharmaceuticals such as T20K, are now within reach.Since cyclotides are gene-encoded plant peptides, Professor David Craik and his team at University

UPM plans capacity reduction in Schongau and accelerates its exit plan in Steyrermühl

(UPM, Helsinki, 22 March 2023 at 11:35 EET) – UPM plans to adapt its uncoated publication paper capacity to a long-term profitable customer demand. The capacity reductions are planned to take place in Germany and Austria: · UPM Communication Papers plans to permanently close paper machine 6 at UPM Schongau, Germany, reducing the annual capacity of uncoated publication papers by 165,000 tonnes by the end of Q2 2023. · UPM Communication Papers accelerates the earlier announced stop of production at its Steyrermühl mill by six months. The exit of a total annual capacity of 320,000

BioStock: Targinta positions itself in the ADC field

The Antibody-Drug Conjugates area has grown rapidly in recent years with several research advances, market approvals, and licensing agreements. A clear example is Pfizer's 43 billion USD acquisition of Seagen announced on March 13. Swedish Targinta, with its unique cancer target and First-in-Class antibodies, has developed a strong position in the ADC field.Read the full article at biostock.se: https://www.biostock.se/en/2023/03/targinta-positions-itself-in-the-adc-field/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

ArcticZymes Technologies announces CEO resignation

Tromsø, March 22nd 2023 – ArcticZymes Technologies ASA (OSE: AZT) announces that the Board of Directors has today accepted the voluntary resignation of Jethro Holter as Chief Executive Officer, due to personal reasons.The resignation will take effect on 30th September 2023 after the required 6 months notice period.  “On behalf of the Board, I want to thank Jethro very much for his outstanding contributions to ArcticZymes over the past 3 years that he has served as our CEO. During that time, Jethro has been instrumental in transforming ArcticZymes into a successful and highly profitable

Minesto participates in Sweden Innovation Days 2023 today

In conjunction with Sweden Innovation Days , Minesto CEO Dr Martin Edlund had the opportunity of being a part of the panel discussion hosted by Vinnova around the topic of “Raw materials supply for the green energy transition.”The free digital event is broadcasted online from CET 16.30 to 17.30. You can register here  to attend the event, you can also watch other presentations and panel discussions once you register. More information on the panel discussion Minesto is taking part in: https://

Invitation to presentation of Dustin's Interim report on March 29

Dustin Group will hold a conference call for investors, analysts and media on March 29 at CET 09:00 am with reference to the release of the Interim report for the second quarter 2022/23.CEO Thomas Ekman and CFO Johan Karlsson will present the financial result for the second quarter 2022/23 and answer questions. The conference call will be held in English. Related presentation material will be available at the corporate website www.dustingroup.com under Investors https://www.dustingroup.com/en/reports before the start of the conference call. Dustin Group will publish the Interim report

SEB’s The Green Bond report: the peak of CO2 emissions?

In the latest issue of SEB’s The Green Bond report, our experts explain how we have now reached the end of the beginning for the clean energy transition, or the point where the annual zero-emission energy growth outpaces the increase in total energy consumption and where absolute CO2 emissions start falling. As the United Nations gathers in New York for the first global conference about water in over fifty years, the report also explores the investment needs and opportunities to achieve the UN’s Sustainable Development Goal 6: clean water and sanitation. The energy shocks of the early

Speqta recruits Daniel Radu as CTO for Bidbrain

Speqta ("SPEQT") has recruited Daniel Radu as Chief Technology Officer for Bidbrain. Daniel has a solid background as tech lead for SaaS and e-commerce companies. Bidbrain, offering an advanced and transparent AI-based service for smarter bidding on Google Shopping ads, is now strengthening its team with a new Chief Technology Officer.Daniel Radu has a background from several companies in SaaS and e-commerce industries and has extensive experience in building both tech teams and scalable technical solutions. Daniel comes most recently from Apica, where he has been involved in

Annual General Meeting of Sandvik Aktiebolag

The shareholders in Sandvik Aktiebolag are convened to the Annual General Meeting to be held on Thursday, April 27, 2023 at 4:00 p.m. at the Göransson Arena, Sätragatan 21, Sandviken, Sweden. Registration will begin at 2:30 p.m. The award of the Wilhelm Haglund medal and the Sandvik Sustainability Award in Memory of Sigrid Göransson will take place at approx. 3:30 p.m. Coffee and tea will be served. RIGHT TO PARTICIPATE AND Notice There are two ways for shareholders to participate in the Meeting: (i) attending the Meeting in person or by proxy, or (ii) participating by postal

Vattenfall secures new credit facility

Vattenfall has secured a credit facility of EUR 3 billion, which is replacing bilateral facilities of EUR 4.3 billion that were established in 2022.The bilateral facilities were established for the purpose of securing Vattenfall’s liquidity during last year’s very volatile energy market. Since then, progress has been made in order to restructure the business for the purpose of reducing the inherent liquidity risks of Vattenfall’s business model. Together with a more stable energy market, this has led to a reduced need for liquidity. The new credit facility amounts to EUR 3 billion. -

BioStock: Abliva’s CEO about the phase II study

In December last year, Abliva initiated a potentially pivotal phase II study with KL1333. The candidate is being developed for the treatment of primary mitochondrial disease in adults, a group of rare diseases that lack effective treatment. CEO Ellen K. Donnelly visited BioStock’s studio to tell us more.See the full interview at biostock.se : https://www.biostock.se/en/2023/03/ablivas-ceo-about-the-phase-ii-study/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Aqilion to recieve 20.1 MSEK after conversion of outstanding warrants

In order to strengthen the company's liquidity and to ensure the continued development of the company's pipeline, on July 27, 2022 the Aqilion Board of Directors decided on to carry out an issue with priority for existing owners. The issue was carried out during the third quarter of 2022 as an issue of units, which brought the company approximately SEK 30.5 million before issue costs. Each unit contained four (4) shares and two (2) options of the subscription series TO1. All warrants (100%) in warrant series TO1 have now been converted to shares, which has added SEK 20.1 million to the

Metsä Board on the 2022 CDP Supplier Engagement Leaderboard

Metsä Board Corporation press release 22.03.2022Metsä Board, part of Metsä Group, has been recognised by CDP for their work to engage with suppliers to jointly tackle climate change. Only the top 8% of companies who disclosed information for the full climate questionnaire achieved a place on the CDP Supplier Engagement Leaderboard. The CDP Supplier Engagement assessment complements the CDP results published in December 2022, in which Metsä Board secured a place on CDP’s prestigious A List for tackling climate change, as well as using water resources and forests sustainably – all three

Metso Outotec’s Annual report for 2022 has been published

Metso Outotec Corporation’s stock exchange release on March 22, 2023, at 10:00 a.m. EETMetso Outotec has today, March 22, 2023, published its Annual report for 2022. The report consists of five sections that are Business overview, Financial review, Corporate governance statement, Remuneration report and GRI supplement.  Business overview comprises strategy, value creation and sustainability. Financial review consists of the Board of Directors' report, financial statements, Auditor’s report and investor information. Metso Outotec’s Board of directors’ report and financial statements is

BioStock: Xbrane's CEO on the launch of Ximluci in Europe

Together with its partner STADA, the biosimilar company Xbrane Biopharma is currently in the process of launching Ximluci, a biosimilar to the reference drug Lucentis for the treatment of a serious eye disease. In connection with the BioStock Investor Meeting, the company's CEO Martin Åmark talked about the product launch, the plans for the upcoming US launch and the licensing plans for the oncology portfolio.Watch the interview with Martin Åmark at biostock.se: https://www.biostock.se/en/2023/03/xbranes-ceo-on-the-launch-of-ximluci-in-europe/ This is a press release from BioStock -

Q4 Report - 31 December 2022

Flexion closes its strongest year to date with another record quarter. Total revenue grows by 108%, gross profit up 147% and adjusted EBITDA hits GBP 1.6mOctober-December 2022 performance · Total revenue increased by 108% to GBP 21.7m (10.5)* · Gross profit increased by 147% to GBP 3.7m (1.5) · Adjusted EBITDA[‡] increased to GBP 1.6m (0.4) · Adjusted profit before tax[#] increased to GBP 1.1m (0.6) · EPS amounted to GBP 2.78 pence (1.28 pence) · Adjusted EPS amounted to GBP 1.88 pence (1.32 pence) · Operating cash flow amounted to GBP 1.2m (0.5) · Cash and cash

There are no items matching the current filter
There are no more items matching the current filter
Back to top